RONNIE DIEM: Open Payments
NPI 1932164324 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 54 payments from 15 companies in 2025. Trend: 2023 $538 · 2024 $631 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $511 |
| Novo Nordisk Inc | 12 | $181 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| PFIZER INC. | 3 | $52 |
| Astellas Pharma US Inc | 3 | $43 |
| Dexcom, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Verona Pharma, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $30 |
Products named: AIRSUPRA, BREZTRI, Ozempic, TRELEGY ELLIPTA, FARXIGA, Veozah, Dexcom G6 Transmitter, CAPLYTA.
Industry payments across DE — which companies pay providers there.
